compound glp-1 medications Compounded" drugs | Health Communication Research Laboratory Injectable Semaglutide | Compounded GLP-1
Description
In the 2022 SURMOUNT-1 study published in NEJM, three doses of tirzepatide were compared with placebo (1:1:1:1) to determine effects on percent weight change over the course of 72 weeks
doi: 10.1002/DMRR.2810
Ozempic (semaglutide) is a valuable option for many of our patients with type 2 diabetes
Desai and Levine reported that weight reductions in GLP-1 RA users were comparable to those observed in non-IBD matched controls [29,36], with greater reductions observed with Tirzepatide [29]
If you develop abdominal pain while taking any of these medications, seek medical attention immediately for an evaluation
